GSE128730 neratinib OVCAR-8 7 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE128730_neratinib_OVCAR-8_7_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE128730_neratinib_OVCAR-8_7_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE128730_neratinib_OVCAR-8_7_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE128730_neratinib_OVCAR-8_7_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

growth arrest specific 5

Gene

small nucleolar RNA host gene 29

Gene

small nucleolar RNA host gene 5

Gene

long intergenic non-protein coding RNA 205

Gene

FGD5 antisense RNA 1

Gene

MAGI2 antisense RNA 3

Gene

CTA-216E10.6

Gene

p53 regulated carcinoma associated Stat3 activating long intergenic non-protein coding transcript

Gene

HERC2 pseudogene 9

Gene

GOLGA2 pseudogene 5

  • Gene

    growth arrest specific 5


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    small nucleolar RNA host gene 5


  • Gene

    long intergenic non-protein coding RNA 205


  • Gene

    FGD5 antisense RNA 1


  • Gene

    MAGI2 antisense RNA 3



  • Gene

    p53 regulated carcinoma associated Stat3 activating long intergenic non-protein coding transcript


  • Gene

    HERC2 pseudogene 9


  • Gene

    GOLGA2 pseudogene 5

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.